Your browser doesn't support javascript.
loading
SAFE: A Novel Microwave Imaging System Design for Breast Cancer Screening and Early Detection-Clinical Evaluation.
Janjic, Aleksandar; Cayoren, Mehmet; Akduman, Ibrahim; Yilmaz, Tuba; Onemli, Emre; Bugdayci, Onur; Aribal, Mustafa Erkin.
Afiliação
  • Janjic A; Mitos Medical Technologies, ITU Ayazaga Ari Teknokent 2-B Block 2-2-E, Maslak, 34469 Istanbul, Turkey.
  • Cayoren M; Electrical and Electronics Engineering Faculty, Istanbul Technical University, Maslak, 34469 Istanbul, Turkey.
  • Akduman I; Mitos Medical Technologies, ITU Ayazaga Ari Teknokent 2-B Block 2-2-E, Maslak, 34469 Istanbul, Turkey.
  • Yilmaz T; Electrical and Electronics Engineering Faculty, Istanbul Technical University, Maslak, 34469 Istanbul, Turkey.
  • Onemli E; Mitos Medical Technologies, ITU Ayazaga Ari Teknokent 2-B Block 2-2-E, Maslak, 34469 Istanbul, Turkey.
  • Bugdayci O; Electrical and Electronics Engineering Faculty, Istanbul Technical University, Maslak, 34469 Istanbul, Turkey.
  • Aribal ME; Mitos Medical Technologies, ITU Ayazaga Ari Teknokent 2-B Block 2-2-E, Maslak, 34469 Istanbul, Turkey.
Diagnostics (Basel) ; 11(3)2021 Mar 16.
Article em En | MEDLINE | ID: mdl-33809770
ABSTRACT
SAFE (Scan and Find Early) is a novel microwave imaging device intended for breast cancer screening and early detection. SAFE is based on the use of harmless electromagnetic waves and can provide relevant initial diagnostic information without resorting to X-rays. Because of SAFE's harmless effect on organic tissue, imaging can be performed repeatedly. In addition, the scanning process itself is not painful since breast compression is not required. Because of the absence of physical compression, SAFE can also detect tumors that are close to the thoracic wall. A total number of 115 patients underwent the SAFE scanning procedure, and the resultant images were compared with available magnetic resonance (MR), ultrasound, and mammography images in order to determine the correct detection rate. A sensitivity of 63% was achieved. Breast size influenced overall sensitivity, as sensitivity was lower in smaller breasts (51%) compared to larger ones (74%). Even though this is only a preliminary study, the results show promising concordance with clinical reports, thus encouraging further SAFE clinical studies.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Diagnostics (Basel) Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Diagnostics (Basel) Ano de publicação: 2021 Tipo de documento: Article